Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
Vivian TangRufei LuKanish MirchiaJessica Van ZifflePatrick DevineJulieann LeeJoanna J PhillipsArie PerryDavid R RaleighCalixto-Hope G LucasDavid A SolomonPublished in: Acta neuropathologica (2023)